NANOSTRUCTURED LINKED HYALURONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS EYE DROPS

The present invention relates to a method for the production of a cross-linked hyaluronic acid with BDDE (1,4-butanediol diglycidyl ether), to be used in the ophthalmic field, which, unlike what is known, is filterable, and therefore sterilizable, at 0.2 microns. La présente invention concerne un pr...

Full description

Saved in:
Bibliographic Details
Main Authors VELLANTE, Marco, SODO, Eugenio, CAVALLO, Giovanni, FOSCHINI, Fulvio, ZANINI, Alessandro
Format Patent
LanguageEnglish
French
Published 17.12.2020
Subjects
AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F,C08G
CHEMISTRY
COMPOSITIONS BASED THEREON
COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
DERIVATIVES THEREOF
GENERAL PROCESSES OF COMPOUNDING
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC MACROMOLECULAR COMPOUNDS
POLYSACCHARIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
THEIR PREPARATION OR CHEMICAL WORKING-UP
WORKING-UP
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method for the production of a cross-linked hyaluronic acid with BDDE (1,4-butanediol diglycidyl ether), to be used in the ophthalmic field, which, unlike what is known, is filterable, and therefore sterilizable, at 0.2 microns. La présente invention concerne un procédé de production d'un acide hyaluronique réticulé avec du BDDE (éther diglycidylique de 1,4-butanediol), à utiliser dans le domaine ophtalmique, qui, contrairement à ce qui est connu, est filtrable, et par conséquent stérilisable, à 0,2 micron.
Bibliography:Application Number: WO2020IB55408